Silesia

Silesia is a prominent Chilean pharmaceutical company that specializes in women's health and pain management. Established in 1934, the company became a market leader in Latin America, particularly known for its extensive portfolio of oral contraceptives and hormone replacement therapies. In 2012, Silesia was acquired by the German pharmaceutical company Grünenthal for approximately 650 million USD, a move that significantly expanded Grünenthal's footprint in the Latin American region. Silesia continues to operate as a major brand within the Grünenthal Group, maintaining its focus on high-quality pharmaceutical products for women's health and therapeutic innovation. The company's portfolio includes well-known regional brands such as Anulette, Acotol, and Vexa, which are widely distributed across the Southern Cone.